PLUS

HEADLINES TREATMENT REGIMENS PUBLISHERS ALLIANCE CONFERENCE COVERAGE TOOLS MULTIMEDIA CME

Apheresis Units, Therapeutic, Phototherapy

Definition : Apheresis units designed to produce an immunosuppressant response in a patient using extracorporeal light activation (i.e., phototherapy) of leukocytes. These units typically separate the blood cell component to be treated (e.g., leukocytes), incorporate a photosensitive drug (e.g., 8-methoxypsoralen), and then photoactivate them using an appropriate light source (e.g., ultraviolet); the treatment may be tailored to the specific needs of a patient. Phototherapy apheresis units are used in the treatment (either curative or palliative) of several diseases, especially those related to T-cell disorders (e.g., palliative treatment of cutaneous effects of T-cell lymphoma, and organ transplant rejection).

Entry Terms : "Phototherapy Apheresis Units" , "Photopheresis Units"

UMDC code : 23138

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-1 of 1 Match(es).

Therakos Inc

Company Type: Parent

For more than 25 years, our engineers, clinicians, and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes.

1-1 of 1 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone